"moderate" MCQ (SBA): Rheumatology
Instant feedback + full explanation. One question, done properly.
Moderate"ACR 2020 recommends treat‑to‑target ULT (allopurinol first‑line) titrated to SU <6 mg/dL in patients with frequent flares. Colchicine alone does not lower urate; probenecid is alternative; pegloticase is for refractory disease."Rheumatology"moderate"
Educational content. Not a substitute for clinical judgement or local policy.